Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program

Ads

You May Also Like

Syneos Health Names Paul Colvin, President, Clinical Solutions

MORRISVILLE, N.C., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully ...

Top Tech Trends from CES 2016

CES is the world’s biggest tech show as hundreds of products are put on ...

Mateon Therapeutics Reports First Quarter 2018 Financial Results

SOUTH SAN FRANCISCO, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), ...